Psybio Therapeutics Corp Stock Price on May 5, 2023
| PSYBF Stock | USD 0.0001 0.00 0.00% |
If you're considering investing in PsyBio Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of PsyBio Therapeutics stands at 0.0001, as last reported on the 29th of November, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. PsyBio Therapeutics is out of control given 3 months investment horizon. PsyBio Therapeutics Corp maintains Sharpe Ratio (i.e., Efficiency) of 0.1, which implies the firm had a 0.1% return per unit of risk over the last 3 months. We have analyzed seventeen different technical indicators, which can help you to evaluate if expected returns of 12.9% are justified by taking the suggested risk. Use PsyBio Therapeutics Variance of 6620260.56, risk adjusted performance of 0.1033, and Coefficient Of Variation of 819.35 to evaluate company specific risk that cannot be diversified away.
PsyBio Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
PsyBio |
Sharpe Ratio = 0.1022
| Best Portfolio | Best Equity | PSYBF | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 126.29 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average PsyBio Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PsyBio Therapeutics by adding it to a well-diversified portfolio.
PsyBio Therapeutics Valuation on May 5, 2023
It is possible to determine the worth of PsyBio Therapeutics on a given historical date. On May 5, 2023 PsyBio was worth 0.0218 at the beginning of the trading date compared to the closed value of 0.021. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of PsyBio Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find PsyBio Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of PsyBio Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against PsyBio Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.02 | 0.02 | 0.02 | 0.02 | 900.00 | |
05/05/2023 | 0.02 | 0.02 | 0.02 | 0.02 | 4,226 |
| 0.02 | 0.02 | 0.02 | 0.02 | 1,000.00 |
| Backtest PsyBio Therapeutics | | | PsyBio Therapeutics History | | | PsyBio Therapeutics Valuation | Previous | Next |
PsyBio Therapeutics Trading Date Momentum on May 5, 2023
| On May 08 2023 PsyBio Therapeutics Corp was traded for 0.02 at the closing time. The highest daily price throughout the period was 0.02 and the lowest price was 0.02 . The daily volume was 1000. The net trading volume on 05/08/2023 added to the next day price rise. The trading delta at closing time to closing price of the next trading day was 1.43% . The trading delta at closing time to current closing price is 19.05% . |
PsyBio Therapeutics Corp Fundamentals Correlations and Trends
By evaluating PsyBio Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among PsyBio Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. PsyBio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About PsyBio Therapeutics Pink Sheet history
PsyBio Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for PsyBio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in PsyBio Therapeutics Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing PsyBio Therapeutics stock prices may prove useful in developing a viable investing in PsyBio Therapeutics
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. Psybio Therapeautics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
PsyBio Therapeutics Pink Sheet Technical Analysis
PsyBio Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
PsyBio Therapeutics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
PsyBio Therapeutics Corp cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
PsyBio Therapeutics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how PsyBio Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PsyBio Therapeutics shares will generate the highest return on investment. By undertsting and applying PsyBio Therapeutics pink sheet market strength indicators, traders can identify PsyBio Therapeutics Corp entry and exit signals to maximize returns
PsyBio Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for PsyBio Therapeutics' price direction in advance. Along with the technical and fundamental analysis of PsyBio Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of PsyBio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1033 | |||
| Jensen Alpha | 301.89 | |||
| Total Risk Alpha | (115.49) | |||
| Treynor Ratio | 3.31 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for PsyBio Pink Sheet analysis
When running PsyBio Therapeutics' price analysis, check to measure PsyBio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PsyBio Therapeutics is operating at the current time. Most of PsyBio Therapeutics' value examination focuses on studying past and present price action to predict the probability of PsyBio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PsyBio Therapeutics' price. Additionally, you may evaluate how the addition of PsyBio Therapeutics to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |